Vanderbilt University’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Vanderbilt University’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-158,786	Closed	-$15.9M	–	86
2025 Q3	$15.9M	Buy	158,786 +40	+0%	+$3.6K	2.64%	7
2025 Q2	$13.2M	Buy	+158,746	New	+$12.7M	2.48%	6
2024 Q1	–	Sell	-118,987	Closed	-$10.6M	–	71
2023 Q4	$10.6M	Buy	118,987 +19	+0%	+$1.41K	2.66%	6
2023 Q3	$8.69M	Hold	118,968	–	–	2.24%	6
2023 Q2	$9.9M	Hold	118,968	–	–	2.53%	4
2023 Q1	$9.07M	Hold	118,968	–	–	2.22%	5
2022 Q4	$9.87M	Hold	118,968	–	–	2.54%	5
2022 Q3	$9.44M	Buy	+118,968	New	+$10M	2.45%	5

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanderbilt University's XBI Position: Q4 2025 in Review

Vanderbilt University sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 158,786 shares — an estimated $15.9M sold.

Vanderbilt University first reported a position in XBI in Q3 2022 and held it in 8 quarters. The position peaked at $15.9M in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Vanderbilt University reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Vanderbilt University sold 158,786 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $15.9M.
Vanderbilt University first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 8 quarters.
Vanderbilt University's State Street SPDR S&P Biotech ETF position peaked at $15.9M in Q3 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Vanderbilt University's 13F filing for Q4 2025, filed 21 Jan 2026.